Exploring the Role of MicroRNAs in Cancer Progression and Treatment Resistance

Thesis Abstract

Abstract
Cancer remains a significant global health challenge, with treatment resistance and disease progression posing major obstacles in improving patient outcomes. The emerging field of microRNAs (miRNAs) has garnered attention for their regulatory roles in cancer biology, including tumor progression and therapeutic resistance mechanisms. This thesis aims to investigate the intricate roles of miRNAs in cancer progression and treatment resistance, focusing on their potential as diagnostic markers and therapeutic targets. The introductory chapter provides a comprehensive overview of the research background, highlighting the significance of understanding miRNA dysregulation in cancer pathogenesis. The problem statement underscores the urgent need to elucidate the molecular mechanisms underlying cancer progression and treatment resistance to develop more effective therapeutic strategies. The objectives of the study are outlined to investigate specific miRNAs implicated in driving cancer progression and mediating resistance to standard therapies. A critical evaluation of the literature in chapter two synthesizes existing knowledge on miRNA dysregulation in various cancer types, emphasizing their impact on key signaling pathways and cellular processes involved in tumor growth and metastasis. The review highlights the potential of miRNAs as biomarkers for cancer diagnosis, prognosis, and treatment response prediction. Chapter three details the research methodology employed to investigate the roles of miRNAs in cancer progression and treatment resistance. The methodology includes sample collection, miRNA profiling techniques, bioinformatic analyses, and experimental validation strategies to elucidate the functional significance of dysregulated miRNAs in cancer biology. The discussion of findings in chapter four provides a comprehensive analysis of the experimental results, emphasizing the role of specific miRNAs in promoting cancer progression and modulating sensitivity to chemotherapy and targeted therapies. The implications of these findings for potential therapeutic interventions are discussed, with a focus on personalized medicine approaches targeting miRNA dysregulation in cancer. Finally, the conclusion and summary chapter synthesizes the key findings of the study, highlighting the novel insights into the roles of miRNAs in cancer progression and treatment resistance. The significance of these findings in advancing our understanding of cancer biology and guiding future research directions is underscored, emphasizing the potential of miRNAs as valuable therapeutic targets in oncology. In conclusion, this thesis provides a comprehensive analysis of the roles of miRNAs in cancer progression and treatment resistance, shedding light on their potential as diagnostic and therapeutic tools in the fight against cancer. The findings presented in this study contribute to the growing body of knowledge on miRNA-mediated mechanisms in cancer biology, paving the way for innovative therapeutic strategies to overcome treatment resistance and improve patient outcomes.